Duration of pertussis immunity after DTaP immunization: a meta-analysis
A McGirr, DN Fisman - Pediatrics, 2015 - publications.aap.org
BACKGROUND AND OBJECTIVES: Pertussis incidence is increasing, possibly due to the
introduction of acellular vaccines, which may have decreased the durability of immune …
introduction of acellular vaccines, which may have decreased the durability of immune …
[HTML][HTML] Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults—A review of safety, immunogenicity …
B Thierry-Carstensen, T Dalby, MA Stevner… - Vaccine, 2013 - Elsevier
Combination vaccines containing a monocomponent acellular pertussis (aP) vaccine,
manufactured at Statens Serum Institut (SSI), Denmark, have successfully controlled …
manufactured at Statens Serum Institut (SSI), Denmark, have successfully controlled …
Outer membrane vesicles as acellular vaccine against pertussis
In this study the development and evaluation of outer membrane vesicles (OMVs) obtained
from Bordetella pertussis as vaccines against pertussis disease is described. SDS-PAGE …
from Bordetella pertussis as vaccines against pertussis disease is described. SDS-PAGE …
A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults
R Booy, O Van Der Meeren, SP Ng, F Celzo… - Vaccine, 2010 - Elsevier
Reduced-antigen-content diphtheria–tetanus–acellular-pertussis (dTpa) vaccines are
predominantly recommended for once-in-a-lifetime use. A second dTpa (Boostrix™ …
predominantly recommended for once-in-a-lifetime use. A second dTpa (Boostrix™ …
Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age
LH Hendrikx, MK Felderhof, K Öztürk, LGH de Rond… - Vaccine, 2011 - Elsevier
Whooping cough has made its comeback and the incidence of pertussis in countries with
widespread pertussis vaccination is most prominent in individuals above 9 years of age. To …
widespread pertussis vaccination is most prominent in individuals above 9 years of age. To …
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …
B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …
the development of safe and immunogenic acellular pertussis vaccines for booster …
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®) A Review of its Properties and Use as a Single-Dose Booster …
PL McCormack - Drugs, 2012 - Springer
Reduced-antigen, combined diphtheria, tetanus and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
What is wrong with pertussis vaccine immunity? Inducing and recalling vaccine-specific immunity
CS Eberhardt, CA Siegrist - Cold Spring Harbor …, 2017 - cshperspectives.cshlp.org
The high incidence of pertussis in vaccinated adolescents suggests the failing of immune
memory. We argue that acellular pertussis vaccines generate memory cells that are …
memory. We argue that acellular pertussis vaccines generate memory cells that are …
A combined DTaP-IPV vaccine (Tetraxim®/Tetravac®) used as school-entry booster: a review of more than 20 years of clinical and post-marketing experience
C Huoi, J Vargas-Zambrano, D Macina… - Expert Review of …, 2022 - Taylor & Francis
Introduction Routine infant primary series and toddler booster vaccination are associated
with waning of antibody levels over time, which can lead to an increased incidence of …
with waning of antibody levels over time, which can lead to an increased incidence of …
Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV)
M Knuf, V Vetter, F Celzo, G Ramakrishnan… - Human …, 2010 - Taylor & Francis
Background: The rising incidence of pertussis amongst adults and adolescents in
industrialised countries could be reduced by replacing tetanus and diphtheria (Td) boosters …
industrialised countries could be reduced by replacing tetanus and diphtheria (Td) boosters …